Ke Da Yu

Summary

Country: China

Publications

  1. pmc Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, 399 Ling Ling Road, Shanghai 200032, People s Republic of China
    BMC Cancer 13:240. 2013
  2. doi request reprint Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai 200032, People s Republic of China
    J Clin Endocrinol Metab 97:E2201-9. 2012
  3. pmc Effect of large tumor size on cancer-specific mortality in node-negative breast cancer
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    Mayo Clin Proc 87:1171-80. 2012
  4. doi request reprint Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects
    Li Xin Qiu
    Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
    Breast Cancer Res Treat 122:521-5. 2010
  5. doi request reprint Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer
    Sheng Chen
    Department of Breast Surgery, Fudan University Shanghai Cancer Center Cancer Institute, Shanghai, People s Republic of China
    Ann Surg Oncol 19:3002-11. 2012
  6. ncbi request reprint Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital, Cancer Institute, Fudan University, Shanghai 200032, PR China
    Breast 16:307-15. 2007
  7. doi request reprint Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Breast Cancer Institute, Fudan University, Shanghai, People s Republic of China
    Breast Cancer Res Treat 121:157-67. 2010
  8. pmc Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China
    Oncologist 18:511-7. 2013
  9. doi request reprint A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer
    Ke Da Yu
    Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    FASEB J 23:2274-87. 2009
  10. doi request reprint XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis
    Li Xin Qiu
    Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
    Breast Cancer Res Treat 122:489-93. 2010

Collaborators

Detail Information

Publications44

  1. pmc Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, 399 Ling Ling Road, Shanghai 200032, People s Republic of China
    BMC Cancer 13:240. 2013
    ..However, the effect of delay in AC initiation on survival is unclear. We performed a systematic review and meta-analysis to determine the relationship between time to AC and survival outcomes...
  2. doi request reprint Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai 200032, People s Republic of China
    J Clin Endocrinol Metab 97:E2201-9. 2012
    ..Subpopulations of ER-positive patients at high risk of breast cancer-specific mortality (BCSM) at 5-10 yr are undetermined...
  3. pmc Effect of large tumor size on cancer-specific mortality in node-negative breast cancer
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    Mayo Clin Proc 87:1171-80. 2012
    ..To examine the relationship between large tumor size and breast cancer-specific mortality (BCSM), especially in a subset of patients with negative lymph nodes (LNs)...
  4. doi request reprint Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects
    Li Xin Qiu
    Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
    Breast Cancer Res Treat 122:521-5. 2010
    ..In conclusion, upto date, there is still not enough evidence to indicate the association of CYP1A2-164 A/C polymorphism and breast cancer development...
  5. doi request reprint Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer
    Sheng Chen
    Department of Breast Surgery, Fudan University Shanghai Cancer Center Cancer Institute, Shanghai, People s Republic of China
    Ann Surg Oncol 19:3002-11. 2012
    ..To investigate the prognostic value of positive-to-negative changes in hormone receptor (HR) status after neoadjuvant chemotherapy (NCT) in patients with HR-positive breast cancer...
  6. ncbi request reprint Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital, Cancer Institute, Fudan University, Shanghai 200032, PR China
    Breast 16:307-15. 2007
    ..This should take into account older ER+/PgR- patients who tend to be resistant to TAM...
  7. doi request reprint Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Breast Cancer Institute, Fudan University, Shanghai, People s Republic of China
    Breast Cancer Res Treat 121:157-67. 2010
    ..In conclusion, although germline mutations of GADD45A is not common in familial breast cancer patients, polymorphisms/haplotypes in GADD45A contribute to breast cancer risk, at least to sporadic breast cancer...
  8. pmc Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China
    Oncologist 18:511-7. 2013
    ..The efficacy and tolerability of two different schedules of paclitaxel, carboplatin, and trastuzumab (PCarH) for HER2-positive, locally aggressive (stage IIB-IIIC) breast cancers were evaluated in this phase II trial...
  9. doi request reprint A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer
    Ke Da Yu
    Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    FASEB J 23:2274-87. 2009
    ..We recommend that a more complicated role for GSTM1 should be considered in breast cancer risk prediction...
  10. doi request reprint XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis
    Li Xin Qiu
    Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
    Breast Cancer Res Treat 122:489-93. 2010
    ....
  11. doi request reprint Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Breast Cancer Institute, Fudan University, 399 Ling Ling Road, Shanghai 200032, China
    Breast Cancer Res Treat 121:485-96. 2010
    ..We infer that GSTM3 catalyzing ability in normal breast tissue might protect against breast carcinogenesis...
  12. doi request reprint A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer
    Sheng Chen
    Department of Breast Surgery, Fudan University Shanghai Cancer Center Cancer Institute, Shanghai, P R China
    J Surg Oncol 105:577-85. 2012
    ....
  13. ncbi request reprint Development and trends of surgical modalities for breast cancer in China: a review of 16-year data
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Fudan University, Shanghai, 200032, People s Republic of China
    Ann Surg Oncol 14:2502-9. 2007
    ..Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported...
  14. doi request reprint Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis
    Ke Da Yu
    Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    Breast Cancer Res Treat 122:251-7. 2010
    ..There is a need for further large studies into the role of these polymorphisms (especially rs5277) and other potentially functional polymorphisms/haplotypes in the COX-2 gene as breast cancer risk modifiers...
  15. doi request reprint Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population
    A Yong Cao
    Department of Oncology, Breast Cancer Institute, Cancer Hospital Cancer Institute, Shanghai Medical College, Fudan University, 270 Dong An Road, Shanghai 200032, People s Republic of China
    Breast Cancer Res Treat 123:133-8. 2010
    ....
  16. pmc Association of HER-2 copy number and HER-2/CEP-17 ratio with neoadjuvant taxane-containing chemotherapy sensitivity in locally advanced breast cancer
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Fudan University, 399 Ling Ling Road, Shanghai, P R China
    Oncologist 17:792-800. 2012
    ..We investigated the effects of FISH-based HER-2 status assessment and aneusomy 17 on responsiveness to neoadjuvant chemotherapy (NAC)...
  17. doi request reprint The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk
    Ke Da Yu
    Department of Breast Surgery, Cancer Center Cancer Institute, Fudan University, 399 Ling Ling Road, Shanghai 200032, People s Republic of China
    Breast Cancer Res Treat 131:27-31. 2012
    ..Further studies, either with larger sample size or regarding other SNPs/haplotypes within the IL-10 gene, are needed to clarify the role of IL-10 in breast carcinogenesis...
  18. doi request reprint Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Fudan University, 399 Ling Ling Road, 200032, Shanghai, People s Republic of China
    Breast Cancer Res Treat 122:483-8. 2010
    ..Identifying a unique SNP as a breast cancer risk predictor remains a very challenging task...
  19. doi request reprint Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Fudan University, 200032 Shanghai, China
    J Cancer Res Clin Oncol 134:1347-54. 2008
    ..The efficacy of adjuvant TAM on ER-/PgR+ patients is still controversial. In this study, we evaluated the efficacy of adjuvant TAM on patients with ER-/PgR+ tumors...
  20. pmc Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes
    A Ji Huang
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    PLoS ONE 7:e35252. 2012
    ..Such polymorphisms could directly affect the binding of microRNA to hundreds of target mRNAs. It remains unknown whether rs4919510:C>G located in the mature miR-608 alters breast cancer susceptibility...
  21. doi request reprint Adjuvant therapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and 5-fluorouracil
    Jun Jie Li
    Department of Breast Surgery, Cancer Hospital, Fudan University, Shanghai, China
    Breast J 17:657-60. 2011
    ..Our study verified that 3 weekly CPF gives the same efficacy and safety as the standard CEF; both CPF and CEF are the effective regimens that can be used in adjuvant chemotherapy of breast cancer...
  22. doi request reprint A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Breast Cancer Institute, Fudan University, Shanghai, People s Republic of China
    Breast Cancer Res Treat 126:37-45. 2011
    ..In summary, the present systematic review suggests that SNP rs4986938 as well as haplotypes in the ESR2 gene might be associated with breast cancer. The need for additional studies examining these issues seems of vital importance...
  23. doi request reprint XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Breast Cancer Institute, Fudan University, 399 Ling Ling Road, 200032 Shanghai, People s Republic of China
    Breast Cancer Res Treat 123:219-25. 2010
    ..Further investigation on the influence of this SNP in modifying the relationship between environment exposures and breast cancer risk is still needed...
  24. pmc A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Fudan University, Shanghai, People s Republic of China
    PLoS ONE 5:e11035. 2010
    ..To investigate the relationship between age and axillary lymph node (LN) involvement in Chinese breast cancer patients, and to replicate a recently identified piecewise relationship between age and LN involvement...
  25. pmc Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer
    Sheng Chen
    Department of Breast Surgery, Fudan University Shanghai Cancer Center Cancer Institute, Shanghai, PR China
    PLoS ONE 7:e41380. 2012
    ..To evaluate the relationship between body mass index (BMI) and response to neoadjuvant chemotherapy (NCT) for breast cancer among Chinese women...
  26. doi request reprint Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component
    Ke Da Yu
    Department of Breast Surgery, Fudan University, Shanghai, People s Republic of China
    Ann Surg Oncol 18:1342-8. 2011
    ..We define those cases as DCIS with invasion component (DCIS-I), and attempt to study the differences of clinicopathological features and immunohistochemical-based subtypes among DCIS, DCIS-Mi, and DCIS-I...
  27. doi request reprint Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53
    Ke Da Yu
    Breast Surgery Department, Breast Cancer Institute, Cancer Hospital, Fudan University, Shanghai, PR China
    Hum Mol Genet 18:2502-17. 2009
    ..Taken together, the data presented here strongly suggest that NQO2 is a susceptibility gene for breast carcinogenesis...
  28. doi request reprint No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis
    Ke Da Yu
    Department of Breast Surgery, Cancer Hospital Cancer Institute, Fudan University, 399 Ling Ling Road, 200032 Shanghai, People s Republic of China
    Breast Cancer Res Treat 122:853-8. 2010
    ..In conclusion, the present meta-analysis strongly suggests that +331G>A in the PgR gene is not associated with breast cancer risk...
  29. doi request reprint Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    Cancer Res 72:408-19. 2012
    ..Our findings also indicate that host-related factors must be considered for individualized chemotherapy...
  30. pmc Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility
    Ao Xiang Chen
    Department of Breast Surgery, Cancer Center, and Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
    PLoS Genet 7:e1002259. 2011
    ..The combined P-value of the two studies was 8.0 × 10⁻⁵. Taken together, our study demonstrates that host genetic variants could disturb the regulation of the let-7/LIN28 double-negative feedback loop and alter breast cancer risk...
  31. doi request reprint Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases
    Shuang Li
    Department of Breast Surgery, Cancer Center Cancer Institute, Fudan University, Shanghai, People s Republic of China
    Ann Surg Oncol 18:2492-9. 2011
    ....
  32. pmc Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer
    Chen Yang
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China
    PLoS ONE 8:e78901. 2013
    ..The underlying mechanism, though it needs to be further investigated, may be that CDR variants could affect the chemokine sequestration ability of CDR proteins. ..
  33. pmc Tailoring adjuvant endocrine therapy for postmenopausal breast cancer: a CYP2D6 multiple-genotype-based modeling analysis and validation
    Ke Da Yu
    Department of Oncology, Shanghai Medical College, Cancer Institute and Cancer Center, Fudan University, Shanghai, People s Republic of China
    PLoS ONE 5:e15649. 2010
    ..The present study established a CYP2D6 multiple-genotype-based model to determine the optimal endocrine therapy for patients harboring wild-type CYP2D6...
  34. doi request reprint RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies
    Ke Da Yu
    Department of Breast Surgery, Cancer Center Cancer Institute, Fudan University, 399 Ling Ling Road, Shanghai, 200032, People s Republic of China
    Breast Cancer Res Treat 126:365-71. 2011
    ..In summary, the present meta-analysis suggests that the RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers...
  35. doi request reprint Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China
    Lei Fan
    Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Institutes of Biomedical Science, Fudan University, 200032 Shanghai, China
    Breast Cancer Res Treat 117:409-16. 2009
    ..Consequently, specific screening protocol should be refined to consider birth cohorts...
  36. doi request reprint A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer
    Ke Da Yu
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, and Shanghai 6th Hospital, 399 Ling Ling Road, Shanghai, 200032, People s Republic of China
    Breast Cancer Res Treat 134:307-13. 2012
    ..Patients' persistence to adjuvant AI medication for postmenopausal, early stage breast cancer is relatively high in the first year and is not significantly increased by adding a patient support program to standard treatment...
  37. doi request reprint The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy
    Sheng Chen
    Authors Affiliations Departments of Breast Surgery, and Pathology, Fudan University Shanghai Cancer Center Cancer Institute Department of Oncology, Shanghai Medical College and Institutes of Biomedical Science, Fudan University, Shanghai, PR China
    Clin Cancer Res 19:6853-62. 2013
    ..This study sought to investigate the prognostic value of the autophagy marker microtubule-associated protein chain 3B (LC3B) in patients with residual tumors after neoadjuvant chemotherapy (NCT) for locally advanced breast cancer (LABC)...
  38. pmc Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer
    Ke Da Yu
    Department of Breast Surgery, Shanghai Cancer Center and Cancer Institute of Fudan University, Shanghai, China
    Clin Cancer Res 19:2723-33. 2013
    ..We hypothesize that there are subgroups of patients with chemoresistant TNBC with different prognosis...
  39. doi request reprint Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects
    Li Xin Qiu
    Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China
    Breast Cancer Res Treat 121:703-8. 2010
    ..15, 95% CI = 1.04-1.28). In conclusion, this meta-analysis suggests that the GSTM1 null genotype is a low-penetrant risk factor for developing breast cancer...
  40. pmc Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery
    Ke Da Yu
    Department of Breast Surgery, Fudan University Shanghai Cancer Center Cancer Institute, Shanghai, PR China
    Oncologist 16:1101-10. 2011
    ..To investigate the recurrence pattern and annual recurrence risk after breast-conserving surgery and compare them with those after mastectomy...
  41. doi request reprint Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes
    Xiao Hua Zeng
    Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Institutes of Biomedical Science, Fudan University, Shanghai, 200032, China
    Breast Cancer Res Treat 125:715-27. 2011
    ..271, 95% CI: 0.081-0.910, P = 0.035). These findings highlight that the multiple loss of ACBs may occur during the development of tumorigenesis and their coexpression in breast cancer is predictive of favorable outcomes...
  42. doi request reprint Preoperative measurement of breast cancer overestimates tumor size compared to pathological measurement
    Yi zhou Jiang
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People s Republic of China
    PLoS ONE 9:e86676. 2014
    ..In the present study, we aimed to determine whether the preoperative measurement of tumor size, by imaging modalities, deviate from the postoperative pathological measurement in breast cancer...
  43. pmc Immediate postmastectomy breast reconstruction showed limited advantage in patient survival after stratifying by family income
    Yi zhou Jiang
    Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, P R China
    PLoS ONE 8:e82807. 2013
    ..Although several studies have casted suspicion upon the oncological safety of immediate breast reconstruction after mastectomy, the potential impact of different reconstruction methods on patient survival remains unclear...
  44. pmc Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis
    Han Chen
    Department of Ophthalmology, Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, People s Republic of China
    PLoS ONE 7:e42464. 2012
    ..To investigate the association between polymorphism rs1061170 (T1277C, Y402H) in age-related macular degeneration (AMD) susceptibility gene Complement Factor H (CFH) and treatment response of neovascular AMD...